Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Akrivis Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Akrivis Technologies

Akrivis Technologies

Angel

Akrivis Technologies: A biopharmaceutical firm offering early detection services, research kits, and more.

HQ
Cambridge, MA, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Akrivis Technologies LLC is a biopharmaceutical company dedicated to the early detection of diseases. The company's core mission is to advance healthcare through innovative diagnostic solutions. Akrivis offers a range of development services, research kits, and related products aimed at improving the accuracy and efficiency of disease detection. Their market focus includes medical research institutions, healthcare providers, and pharmaceutical companies seeking advanced diagnostic tools.

Notable affiliated individuals and investors in Akrivis Technologies include experts in biopharmaceuticals and diagnostics. The company has achieved significant milestones in the development of early detection technologies, contributing to more timely and accurate diagnoses. Akrivis's impact is seen in its enhancement of research capabilities and its support for healthcare advancements, ultimately aiming to improve patient outcomes through early intervention.

Akrivis Technologies - Similar Companies

Akili Labs logo

Akili Labs

Accelevir Diagnostics logo

Accelevir Diagnostics

Amplified Sciences logo

Amplified Sciences

Insightiv Technologies logo

Insightiv Technologies

Zymeron logo

Zymeron

zymeron.com

BioAnalytics logo

BioAnalytics

Aviir logo

Aviir

aviir.com

Durin Technologies logo

Durin Technologies

Avant Diagnostics logo

Avant Diagnostics

Gaskiya Diagnostics logo

Gaskiya Diagnostics

Aegirbio logo

Aegirbio

aegirbio.com

OmniVis logo

OmniVis

Aliva Biopharmaceuticals logo

Aliva Biopharmaceuticals

ActivSignal logo

ActivSignal

activsignal.com

Attometrics logo

Attometrics

Akrivis Technologies - Quick Facts

Who are Akrivis Technologies' competitors?

Companies similar to Akrivis Technologies include Akili Labs, Accelevir Diagnostics, Amplified Sciences and Insightiv Technologies.

When was Akrivis Technologies founded?

Akrivis Technologies was founded in 2009.

Where is Akrivis Technologies' headquarters located?

Akrivis Technologies' headquarters is located in Cambridge, MA, US.

When was Akrivis Technologies' last funding round?

Akrivis Technologies' most recent funding round was for $174.7k (USD) in December 2015.

How much has Akrivis Technologies raised to-date?

As of Dec 16, 2015, Akrivis Technologies has raised a total of $674.7k (USD).

How many employees does Akrivis Technologies have?

Akrivis Technologies has 2 employees as of Feb 4, 2024.

Akrivis Technologies - Classification

Industry
  • Professional Service Companies
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Research Kits
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research